President-elect Trump nominated Jim O'Neill, an investor and close associate of Peter Thiel, as the Deputy Secretary of Health and Human Services. O'Neill aims to improve management and transparency to enhance America's health. Critics raise concerns over his views on FDA drug approval processes.